Blog | Veristat Insightful Perspectives

Regulatory Guidance Monthly Review - December 2019

December 2019 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA)  that are pertinent to the governance of clinical trials and drug, biologic, or medical device development and approval.   Below are the relevant links to updates provided in December 2019.


Read More